Immediate Impact
1 by Nobel laureates 1 from Science/Nature 62 standout
Citing Papers
Cross-priming in cancer immunology and immunotherapy
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Arun K. Singavi being referenced
Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer
2018
Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs)
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Arun K. Singavi | 54 | 59 | 241 | 76 | 75 | 14 | 345 | |
| Mark Tuthill | 74 | 59 | 138 | 49 | 51 | 19 | 323 | |
| Jeanne M. Rothberg | 64 | 65 | 150 | 130 | 92 | 10 | 321 | |
| Sandra Sapia | 33 | 47 | 115 | 68 | 64 | 16 | 306 | |
| L. Tedeschi | 115 | 44 | 166 | 79 | 163 | 15 | 324 | |
| Jake Allred | 46 | 34 | 251 | 32 | 80 | 13 | 363 | |
| Laura Stephanie Miller | 224 | 47 | 187 | 62 | 50 | 11 | 400 | |
| Ivan P. Law | 82 | 109 | 96 | 51 | 133 | 15 | 341 | |
| Valentina Bozzoli | 84 | 83 | 123 | 30 | 156 | 16 | 336 | |
| T. I. Robertson | 66 | 83 | 88 | 37 | 112 | 13 | 303 | |
| José R. Borbolla‐Escoboza | 46 | 21 | 107 | 126 | 71 | 18 | 372 |
All Works
Login with ORCID to disown or claim papers
Loading papers...